Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Apr 21 424B5 Prospectus supplement for primary offering
- 29 Apr 21 424B5 Prospectus supplement for primary offering
- 9 Apr 21 424B5 Prospectus supplement for primary offering
- 31 Mar 21 424B5 Prospectus supplement for primary offering
- 14 Jan 21 424B5 Prospectus supplement for primary offering
- 9 Oct 20 424B5 Prospectus supplement for primary offering
- 9 Oct 20 424B5 Prospectus supplement for primary offering
- 7 Oct 20 424B5 Prospectus supplement for primary offering
- 5 Oct 20 424B5 Prospectus supplement for primary offering
- 24 Sep 20 EFFECT Notice of effectiveness
- 23 Sep 20 424B3 Prospectus supplement
-
11 Sep 20 S-3 Shelf registration
JAGX similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Jaguar Health, Inc.
San Francisco, California
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated April 10, 2019, relating to the 2018 consolidated financial statements of Jaguar Health, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP | ||
San Jose, California | ||
September 11, 2020 |